Blue Water Life Science Advisors, LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Blue Water Life Science Advisors, LP disclosed 9 US equity positions worth $112.9m in its Q4 2024 13F filing. The largest position was NTRA at 35.7% of the reported book, followed by GH and CDNA. Against the Q3 2024 filing, it opened 1 new position, added to 2 and reduced 2 among the top 9 holdings.
What did Blue Water Life Science Advisors, LP own in Q4 2024? Top 9 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | NTRA NATERA INC | Healthcare | 35.7% | $40.3m | 254,794 | -12% | reduced |
| 2 | GH GUARDANT HEALTH INC | Healthcare | 18.8% | $21.2m | 694,047 | 54% | added |
| 3 | CDNA CAREDX INC | Healthcare | 11.5% | $12.9m | 604,000 | 0% | held |
| 4 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 11.4% | $12.9m | 2,145,145 | 0% | held |
| 5 | AKOYA BIOSCIENCES INC | 9.5% | $10.8m | 4,697,785 | 0% | held | |
| 6 | PSNL PERSONALIS INC | Healthcare | 5.8% | $6.5m | 1,132,900 | 13% | added |
| 7 | EXK EXACT SCIENCES CORP | Basic Materials | 3.9% | $4.4m | 78,843 | -69% | reduced |
| 8 | TEM TEMPUS AI INC | Healthcare | 2.7% | $3.0m | 90,000 | – | new |
| 9 | QTRX QUANTERIX CORP | Healthcare | 0.7% | $833.3k | 78,393 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.